Man Tea Rock-Hard Formula

The Best Ways to Treat Erectile Dysfunction

Get Instant Access

1. Mant D. Can randomised trials inform clinical decisions about individual patients? Lancet 1999;353:743-6.

2. Eypasch E. The individual patient and evidence-based medicine - a conflict? Langenbecks Arch Surg 1999;384: 417-22.

3. Williams H. Dowling Oration 2001. Evidence-based dermatology - a bridge too far? Clin Exp Dermatol 2001;26:714-24.

4. Dans AL, Dans LF, Guyatt GH, Richardson S. Users' guides to the medical literature: XIV. How to decide on the applicability of clinical trial results to your patient. Evidence-Based Medicine Working Group. JAMA 1998;279:545-9.

5. Li Wan Po, A. Dictionary of Evidence-based Medicine Oxford: Radcliffe Medical Press, 1998:52.

6. Roberts RJ, Casey D, Morgan DA, Petrovic M. Comparison of wet combing with malathion for treatment of head lice in the UK: a pragmatic randomised 19.

controlled trial. Lancet 2000;356:540-4.

7. Virag R. Indications and early results of sildenafil (Viagra)

in erectile dysfunction. Urology 1999;54:1073-7. 20.

8. Nikles CJ, Glasziou PP, Del Mar CB, Duggan CM. Mitchell G. N of 1 trials. Practical tools for medication management. Aust Fam Physician 2000;29:1108-12. 21.

9. Lennard L. Therapeutic drug monitoring of cytotoxic drugs. Br J Clin Pharmacol 2001;52 (Suppl 1):75S-87S.

10. Bakan D. The general and the aggregate: a 22. methodological distinction. Percept Mot Skills 1955;5:

11. Straus SE, McAlister FA. Evidence-based medicine: a commentary on common criticisms. Can Med Assoc J 2000;163:837-41.

12. Hoare C, Li Wan Po A, Williams H. Systematic review of 24. treatments for atopic eczema. Health Technol Assess 2000;4(37).

13. Charman C, Williams H. Outcome measures of disease severity in atopic eczema. Arch Dermatol2000;136: 763-9. 25.

14. Olsen EA. Topical minoxidil in the treatment of androgenetic alopecia in women. Cutis 1991;48:243-8.

15. Charman C, Williams HC. The problem of un-named scales 26. for measuring atopic eczema. J Invest Dermatol in press).

16. Marshall M, Lockwood A, Bradley C, Adams C, Joy C, 27. Fenton M. Unpublished rating scales: a major source of bias in randomised controlled trials of treatments for schizophrenia. Br J Psychiatry 2000;176:249-52. 28.

17. Cook RJ, Sackett DL. The number needed to treat: a clinically useful measure of treatment effect. BMJ 29. 1995;310:452-4.

18. Devereaux PJ, Anderson DJ, Gardner MJ et al. Differences between perspectives of physicians and patients on anticoagulation in patients with atrial fibrillation: an observational study. BMJ 2001;323:1218-22. Hollis S, Campbell F. What is meant by intention to treat analysis? Survey of published randomised controlled trials. BMJ 1999;319:670-4.

Eypasch E, Lefering R, Kum CK, Troidl H. Probability of adverse events that have not yet occurred: a statistical reminder. BMJ 1995;311:619-20. Levine M, Whelan T. Decision-making process-communicating risk/benefits: is there an ideal technique? J Natl Cancer Inst Monogr 2001;30:143-5. Thornton JG, Lilford RJ, Johnson N. Decision analysis in medicine. BMJ 1992;304:1099-103. Ashcroft DM, Li Wan Po A, Williams HC, Griffiths CE. Cost-effectiveness analysis of topical calcipotriol versus short-contact dithranol in the treatment of mild to moderate plaque psoriasis. Pharmacoeconomics 2000;18:469-76. McAlister FA, Straus SE, Guyatt GH, Haynes RB. Users' guides to the medical literature: XX. Integrating research evidence with the care of the individual patient. Evidence-Based Medicine Working Group. JAMA 2000;283:2829-36. Gibbs S. Losing touch with the healing art: dermatology and the decline of pastoral doctoring. J Am Acad Dermatol 2000;43:875-8.

Cotterill JA. Dermatological games. Br J Dermatol 1981;105:311-20.

Johnson SR, Dunn BK, Anthony M. Defining benefits and risks for SERMs in clinical trials and clinical practice. Ann NY Acad Sci 2001;949:304-14.

Williams HC, Monk B. Creeping eruption stopped in its tracks by albendazole. Clin Exp Derm 1989;14:355-6. Caumes E, Carriere J, Datry A, Gaxotte P, Danis M, Gentilini M. A randomized trial of ivermectin versus albendazole for the treatment of cutaneous larva migrans. Am J Trop Med Hygiene 1993;49:641-4.

Was this article helpful?

0 0
Invisible Viagara

Invisible Viagara

You are about to discover the "little-known" techniques, tricks and "mind tools" that will show you how to easily "program" your body and mind to produce an instant, rock-hard erection. Learn how to enjoy all of the control, confidence and satisfaction that comes from knowing you can always "rise to the challenge" ... and never have to deal with embarrassment, apologies, shyness or performance anxiety in the bedroom, ever again.

Get My Free Ebook

Post a comment